Related Experiment Video
Updated: May 27, 2026

Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
Published on: October 16, 2018
Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to
Natalie J Griffiths1, Darryl J Hill, Elena Borodina
1Schools of Cellular & Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Abstract:
Complement evasion is an important survival strategy of Neisseria meningitidis (Nm) during colonization and infection. Previously, we have shown that Nm Opc binds to serum vitronectin to inhibit complement-mediated killing. In this study, we demonstrate meningococcal interactions with vitronectin via a novel adhesin, Msf (meningococcal surface fibril, previously NhhA or Hsf). As with Opc, Msf binds preferentially to activated vitronectin (aVn), engaging at its N-terminal region but the C-terminal heparin binding domain may also participate. However, unlike Opc, the latter binding is not heparin-mediated. By binding to aVn, Msf or Opc can impart serum resistance, which is further increased in coexpressers, a phenomenon dependent on serum aVn concentrations. The survival fitness of aVn-binding derivatives was evident from mixed population studies, in which msf/opc mutants were preferentially depleted. In addition, using vitronectin peptides to block Msf-aVn interactions, aVn-induced inhibition of lytic C5b-9 formation and of serum killing could be reversed. As Msf-encoding gene is ubiquitous in the meningococcal strains examined and is expressed in vivo, serum resistance via Msf may be of significance to meningococcal pathogenesis. The data imply that vitronectin binding may be an important strategy for the in vivo survival of Nm for which the bacterium has evolved redundant mechanisms.
Insights
Neisseria meningitidis uses a novel protein, Msf, to bind activated vitronectin, enhancing its survival against the human complement system. This binding mechanism provides serum resistance, crucial for meningococcal pathogenesis.
Area of Science:
- Microbiology
- Immunology
- Bacterial Pathogenesis
Background:
- Neisseria meningitidis (Nm) employs complement evasion for survival during infection.
- The Nm adhesin Opc binds serum vitronectin to inhibit complement-mediated killing.
- Vitronectin is a key serum protein involved in immune responses and coagulation.
Purpose of the Study:
- To identify and characterize novel meningococcal adhesins involved in vitronectin binding.
- To elucidate the mechanism by which meningococcal adhesins mediate complement resistance.
- To assess the role of vitronectin binding in meningococcal pathogenesis and survival.
Main Methods:
- Bacterial surface protein characterization and binding assays.
- Analysis of complement-mediated killing and serum resistance.
- In vitro and in vivo competition assays using bacterial mutants.
- Peptide-based inhibition of protein-vitronectin interactions.
Main Results:
- A novel adhesin, meningococcal surface fibril (Msf), mediates binding to activated vitronectin (aVn).
- Both Msf and Opc bind aVn, conferring serum resistance, with enhanced resistance in co-expressing strains.
- Blocking Msf-aVn interactions reversed aVn-mediated inhibition of complement component C5b-9 formation and serum killing.
- Mutants lacking Msf or Opc were depleted in mixed population survival studies, indicating their importance for fitness.
Conclusions:
- Meningococcal surface fibril (Msf) is a novel adhesin that binds activated vitronectin, contributing to serum resistance.
- Vitronectin binding represents a significant survival strategy for Neisseria meningitidis, with redundant mechanisms (Opc and Msf) evolved for pathogenesis.
- Targeting Msf-vitronectin interactions could be a potential therapeutic strategy against meningococcal infections.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Cryptococcal Meningitis
Complement System
Viral Meningitis
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

